Clinical Trial Update: Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of imatinib and artesunate for chronic myeloid leukemia. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Artesunate (artesunate)
• Gleevec (Imatinib)

Snippet

Sponsor: Obafemi Awolowo University | Conditions: Chronic Myeloid Leukemia (CML) | Phase 2 | Status: ACTIVE_NOT_RECRUITING